UBLITUXIMAB-XIIY for Relapsing multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where UBLITUXIMAB-XIIY was used for Relapsing multiple sclerosis.
Most Reported Side Effects for UBLITUXIMAB-XIIY
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 481 | 53.4% | 0 | 18 |
| Fatigue | 48 | 5.3% | 0 | 2 |
| Headache | 34 | 3.8% | 0 | 3 |
| Malaise | 22 | 2.4% | 0 | 0 |
| Inappropriate schedule of product administration | 21 | 2.3% | 0 | 0 |
| Product dose omission issue | 19 | 2.1% | 0 | 1 |
| Asthenia | 18 | 2.0% | 1 | 3 |
| Drug ineffective | 18 | 2.0% | 1 | 0 |
| Nausea | 18 | 2.0% | 1 | 2 |
| Dizziness | 17 | 1.9% | 1 | 1 |
| Covid-19 | 16 | 1.8% | 0 | 1 |
| Off label use | 16 | 1.8% | 0 | 1 |
| Pyrexia | 16 | 1.8% | 0 | 1 |
| Urinary tract infection | 16 | 1.8% | 0 | 3 |
| Back pain | 15 | 1.7% | 0 | 0 |
Other Indications for UBLITUXIMAB-XIIY
Multiple sclerosis (661)
Product used for unknown indication (173)
Relapsing-remitting multiple sclerosis (18)
Other Drugs Used for Relapsing multiple sclerosis
OCRELIZUMAB (6,883)
OFATUMUMAB (3,705)
FINGOLIMOD (851)
GLATIRAMER (375)
ALEMTUZUMAB (350)
SIPONIMOD (194)
INTERFERON BETA-1A (192)
NATALIZUMAB (140)
RITUXIMAB (136)
OZANIMOD (127)